Posts by Mark C. Poznansky, MD, PhD
-
MGH Research Scholars Respond to COVID-19
This video highlights how the MGH Research Scholars rapidly mobilized to address key medical and scientific challenges posed by COVID-19.
-
Why Pursuing Multiple Vaccines May Be the Best Way to End the COVID-19 Pandemic
The race to test and approve a vaccine for the SARS-CoV-2 virus is moving quickly, with over 100 vaccines now in development. The goal is to identify and accelerate multiple promising candidates into production. Here, Mass General investigators highlight the strengths and weaknesses of the various approaches and what the next key steps needed are to develop and distribute a new vaccine quickly.
-
Review: Doubt Cast on Use of Chloroquine and Hydroxychloroquine for COVID-19
Anecdotal studies suggest that the drugs chloroquine and hydroxychloroquine may be effective against SARS-CoV-2, the virus that caused the COVID-19 pandemic. A new review of the science and clinical experiences of the drugs casts doubt on their utility for COVID-19.
Biography
Mark Poznansky, MD, PhD, is an associate professor of medicine at Harvard Medical School, an attending physician in infectious diseases medicine at the Massachusetts General Hospital (MGH), and Director of the Vaccine and Immunotherapy Center at MGH. He holds a doctoral degree Cambridge University and a medical degree from University of Edinburgh. His clinical subspecialization includes the treatment of infection in immune-compromised patients. The Poznansky laboratory works at the interface between scientific discovery and medical product development, discovering novel immune processes, defining their molecular mechanisms and exploring their relevance to the development of vaccines and immunotherapies for cancer, infectious diseases and type I diabetes. Their work is funded by the National Institutes of Health, Juvenile Diabetes Research Foundation, The Marsha Rivkin Center and other private foundations.
